Visit VelacurTM at 2021 Annual GHAPP Conference

If you specialize in the management of patients with chronic liver disease, visit our booth at the 2021 Annual GHAPP Conference to learn more about VelacurTM, the first handheld 3D liver health assessment solution.

Hosted September 9-11, the GHAPP Conference is the only conference specifically designed by and for advanced practice providers (APPs) to review the latest developments on multidisciplinary treatment for patients with GI disorders and chronic liver disease.

Interested in a private demo of Velacur? Send us your request: https://www.sonicincytes.com/velacur-demo/

Follow us on LinkedInTwitter, and YouTube, and subscribe to our e-newsletter below.

Sync up

with Sonic

Be in-the-know on all our latest news!

Subscribe to our e-newsletter.

Julia PinterMarketing Director

Julia Pinter brings over a decade of medical technology marketing experience spanning product commercialization, launch strategy, and sales enablement. Prior to joining Sonic Incytes, she served as Director of Global GI Product Marketing at PENTAX Medical, where she led global downstream marketing for the company’s largest portfolio — driving commercial launches of next-generation endoscopes, imaging systems, and AI platforms across the Americas, Europe, and Asia-Pacific. At Sonic Incytes, Julia leads downstream marketing initiatives to expand awareness and accelerate adoption of Velacur One®, translating its clinical and economic value into programs that support broader adoption of non-invasive liver assessment.